Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collplant Biotechnologies Ltd ADR (CLGN)

Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,781
  • Shares Outstanding, K 12,776
  • Annual Sales, $ 520 K
  • Annual Income, $ -16,610 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.47
  • Price/Sales 7.05
  • Price/Cash Flow N/A
  • Price/Book 1.97

Options Overview Details

View History
  • Implied Volatility 161.33% (-134.20%)
  • Historical Volatility 78.09%
  • IV Percentile 23%
  • IV Rank 10.51%
  • IV High 944.80% on 10/27/25
  • IV Low 69.34% on 09/19/25
  • Expected Move (DTE 5) 0.4675 (31.80%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 109
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 608
  • Open Int (30-Day) 777
  • Expected Range 1.0025 to 1.9375

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.34
  • Growth Rate Est. (year over year) +293,923.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3000 +13.08%
on 12/18/25
1.9280 -23.76%
on 12/11/25
-0.3000 (-16.95%)
since 12/09/25
3-Month
1.3000 +13.08%
on 12/18/25
2.6800 -45.15%
on 10/20/25
-0.8700 (-37.18%)
since 10/09/25
52-Week
1.3000 +13.08%
on 12/18/25
4.9800 -70.48%
on 05/29/25
-2.8975 (-66.34%)
since 01/08/25

Most Recent Stories

More News
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

REHOVOT, Israel , Nov. 26, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 1.4700 (+2.08%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

REHOVOT, Israel , Nov. 18, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 1.4700 (+2.08%)
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

-- New North American logistics center will provide expanded distribution for CollPlant's rhCollagen and BioInks as well as enable logistical efficiencies --

CLGN : 1.4700 (+2.08%)
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology

REHOVOT, Israel , Oct. 20, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its...

CLGN : 1.4700 (+2.08%)
CollPlant and Mayo Clinic Unveil Humanized 3D Bioprinted Skin Model

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update...

CLGN : 1.4700 (+2.08%)
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

REHOVOT, Israel , Oct. 16, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its...

CQPTY : 9.0000 (+1.69%)
CLGN : 1.4700 (+2.08%)
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the upcoming clinical trials

CQPTY : 9.0000 (+1.69%)
CLGN : 1.4700 (+2.08%)
CollPlant Expands the Distribution of its VergenixSTR Product in Europe

REHOVOT, Israel , Sept. 15, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or ' CollPlant ' , a regenerative and aesthetics medicine company developing innovative...

CQPTY : 9.0000 (+1.69%)
CLGN : 1.4700 (+2.08%)
CollPlant to Present at the 2025 International Conference on Biofabrication

REHOVOT, Israel , Sept. 2, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products...

CLGN : 1.4700 (+2.08%)
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

REHOVOT, Israel , Aug. 25, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and...

CQPTY : 9.0000 (+1.69%)
CLGN : 1.4700 (+2.08%)

Business Summary

CollPlant Biotechnologies Ltd. is a regenerative medicine company. It is focused on 3D bioprinting of tissues and organs, medical aesthetics and on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CollPlant Biotechnologies Ltd., formerly knonw...

See More

Key Turning Points

3rd Resistance Point 1.5847
2nd Resistance Point 1.5473
1st Resistance Point 1.5087
Last Price 1.4700
1st Support Level 1.4327
2nd Support Level 1.3953
3rd Support Level 1.3567

See More

52-Week High 4.9800
Fibonacci 61.8% 3.5742
Fibonacci 50% 3.1400
Fibonacci 38.2% 2.7058
Last Price 1.4700
52-Week Low 1.3000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar